Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Expanded Access Listings

You can search in free text – simply type the disease, drug, company name, or other detail into the Search bar below and click Apply
Displaying 440 of 465

Affinia Therapeutics

EA Page: https://affiniatx.com/early-access-policy/

Repertoire Immune Medicines

EA Page: https://www.repertoire.com/expanded-access-policy

Idience Co., Ltd.

EA Page: https://nam02.safelinks.protection.outlook.com/?url=https%3A//335b487a-eb88-405…

Shanghai Argo Biopharmaceutical Co., Ltd.

EA Page: https://www.argobiopharma.com/expanded-access/

A2 Biotherapeutics, Inc.

EA Page: https://www.a2bio.com/our-pipeline/

Pulmongene

EA Page: https://www.pulmongene.com/wp-content/uploads/2026/04/Pulmongenes-Expanded-Acce…

Vidamax Therapeutics LLC

Celltrion, Inc.

EA Page: https://www.celltrion.com/en-us

Context Therapeutics Inc.

EA Page: https://www.contexttherapeutics.com/expanded-access

Bristol-Myers Squibb

Expanded Access for Apixaban

Conditions:

This is an expanded access designed to provide access to apixaban for eligibleparticipants.

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 39
  • Page 40
  • Page 41
  • Page 42
  • Page 43
  • Current page 44
  • Page 45
  • Page 46
  • Page 47
  • Next page ››
  • Last page Last »

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA